{
  "profile": "AGGRESSIVE",
  "ticker": "JNJ",
  "timestamp": "2025-12-01T18:08:51.208383",
  "analysis_date": "2025-05-23",
  "stance": "HOLD",
  "position_pct": 0,
  "confidence": "MEDIUM",
  "agrees_with_math": true,
  "more_aggressive_than_math": false,
  "aggression_reasoning": "The current risk/reward ratio does not justify a bold investment despite potential catalysts.",
  "opportunity_assessment": "The upcoming ASCO conference could shift sentiment positively if the oncology portfolio shows promise, which the market may not fully account for.",
  "catalyst_assessment": "Both catalysts on May 28, 2025, have the potential to significantly impact stock perception, especially if results exceed expectations.",
  "risks_accepting": "Accepting the high valuation and regulatory scrutiny risks, which could lead to significant downside if not managed properly.",
  "stop_loss_pct": 10,
  "profit_targets": [
    5,
    5,
    7.0
  ],
  "reasoning": "While the upside potential exists, the risks outweigh the benefits at this time. Holding off on new positions allows for reassessing post-catalyst results.",
  "key_factors": [
    "upcoming ASCO conference",
    "regulatory scrutiny",
    "earnings momentum"
  ],
  "trading_plan": {
    "entry": "Monitor ASCO conference outcomes closely for entry signals.",
    "scaling": "Consider scaling in if positive sentiment develops post-catalysts.",
    "exit_strategy": "Set profit targets based on market reaction to catalysts, aiming for a 5-7% gain."
  },
  "vs_research_manager": "While the research manager suggests selling, I see potential in the catalysts that could lead to short-term gains despite the overall risk.",
  "calculated_metrics": {
    "upside_pct": 3.8,
    "downside_pct": 4.5,
    "risk_reward_ratio": 0.84,
    "expected_value": -0.51,
    "asymmetry_score": -0.16,
    "bull_conviction": "MEDIUM",
    "catalyst_count": 2,
    "bull_prob_pct": 30.0,
    "bear_prob_pct": 36.7,
    "math_suggested_stance": "AVOID",
    "math_suggested_position": 0.0,
    "rr_threshold_strong_buy": 2.0,
    "rr_threshold_buy": 1.5
  },
  "risk_reward_ratio": 0.84,
  "expected_value": -0.51,
  "guardrail_corrections": [],
  "guardrail_warnings": [],
  "validation_passed": true,
  "validation_score": 100
}